AVXL | Anavex Life Sciences Corp
Category: Consumer goods
Quick infos Headquarters: New York City, New York, United States Trade prices Volume: 40.9M Market Cap: 797.31M Prev closed: 20.99 Open: 19.91 High: 20.32 Low: 16.95 52 week low: 3.61 52 week high: 28.7 Dividends: No Dividends Next ER: May 9, 2023
Earnings History Date EPS / Forecast Revenue / Forecast August 10, 2023 May 9, 2023 -0.17 / -0.1883- / -February 7, 2023 -0.17 / -0.19- / -November 28, 2022 -0.18 / -0.165- / -August 9, 2022 -0.16 / -0.1538- / -view more
Historical Data Date Price Open High Low Vol Change ER May 8, 2023 8.41 8.42 8.45
8.2
874K -0.36% May 5, 2023 8.44 8.5 8.63
8.41
796K 0.48% May 4, 2023 8.4 8.32 8.48
8.11
796K 0.72% May 3, 2023 8.34 8.05 8.5
8.03
1.3M 4.25% May 2, 2023 8 8.28 8.39
7.95
994K -2.68% May 1, 2023 8.22 8.15 8.27
7.98
854K 0.98% Apr 28, 2023 8.14 8.2 8.23
8.05
693K -0.61% Apr 27, 2023 8.19 8.31 8.37
8.06
727K -0.61% Apr 26, 2023 8.24 7.76 8.29
7.66
1.2M 6.05% Apr 25, 2023 7.77 7.81 7.88
7.65
696K -1.02% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Hot Stocks: BYND, TSN drop on downgrade; BUD upgrade; AVXL slumps on business update seekingalpha.com Nov 29, 2022 2:35 am Biogen drops after report on second death linked to Alzheimer’s candidate seekingalpha.com Nov 29, 2022 1:46 am ONCS, BVS and MIMO among mid-day movers seekingalpha.com Nov 29, 2022 1:38 am
Does Anavex Life Sciences (AVXL) Have the Potential to Rally 265% as Wall Street Analysts Expect? finance.yahoo.com May 25, 2022 9:55 am
Here's why meme stocks are hinting at another flashy rally for `junk stocks` finance.yahoo.com May 13, 2022 4:17 pm
Anavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tuesday May 10, 2022 finance.yahoo.com May 3, 2022 7:00 am
How Anavex Extended Its 5-Week Rally On Promising Results In Rett Syndrome investors.com Apr 27, 2022 4:10 pm
Dow Jones Today Aims To Snap Sell-Off As Nasdaq Reverses; Chevron, Caterpillar Rebound; Yields Edge Up Ahead Of Powell Testimony investors.com Apr 27, 2022 10:02 am Anavex Higher on Phase 2 Progress With Parkinson's Drug thestreet.com Apr 27, 2022 7:04 am Anavex drops 16% after fiscal 2022 update seekingalpha.com Nov 29, 2022 12:34 am Anavex Life Sciences GAAP EPS of -$0.18 misses by $0.01 seekingalpha.com Nov 28, 2022 8:01 pm Anavex therapy for Fragile X syndrome gets FDA orphan drug status seekingalpha.com Nov 7, 2022 8:55 pm Bipartisan bill aims to get CMS to cover Alzheimer's antibody treatments seekingalpha.com Oct 6, 2022 10:58 pm Biogen, Eisai cool off after massive run-up following lecanemab Alzheimer's data seekingalpha.com Sep 30, 2022 2:07 am Many Alzheimer's drug developers close significantly higher thanks to Biogen, Eisai data seekingalpha.com Sep 29, 2022 6:01 am Biogen, Eisai drive rally in Alzheimer’s stocks as lecanemab succeeds in late-stage trial seekingalpha.com Sep 28, 2022 6:43 pm Anavex wins new U.S. patent for lead candidate seekingalpha.com Sep 21, 2022 7:39 pm Anavex Life Sciences GAAP EPS of -$0.16 beats by $0.01 seekingalpha.com Aug 9, 2022 7:58 pm Anavex Life Sciences Q3 2022 Earnings Preview seekingalpha.com Aug 9, 2022 5:35 am Anavex gains on the effect of Alzheimer’s drug on genes seekingalpha.com Aug 1, 2022 8:46 pm This company doesn't provide a dividend.
Talk about Anavex Life Sciences Corp below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis